In particular, on post-stroke days 3 and 9, Cysteine and glycine-rich protein 3 (Csrp3) was included in the analysis due to its expression meeting the differential screening criteria, and its interaction with the differentially expressed thin filament proteins was predicted in both cases. The gene discussed is CSRP3; the disease is Stroke.